Exposure to 5-Alpha Reductase Inhibitors and Spironolactone Is Not Associated With Increased Odds of Gynecologic Tumors in a Large Cohort Study of Patients With Alopecia. Article uri icon

Overview

publication date

  • May 21, 2025

Identity

Scopus Document Identifier

  • 105005863862

Digital Object Identifier (DOI)

  • 10.1111/ijd.17871

PubMed ID

  • 40400094

Additional Document Info

volume

  • 64

issue

  • 11